Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CBY1-interacting BAR domain-containing protein 1 (CIBAR1) is a membrane-associated protein encoded by the FAM92A gene, notable for its BAR (Bin/Amphiphysin/Rvs) domain that enables binding to negatively charged phospholipids and induction of membrane curvature. CIBAR1 plays crucial roles in maintaining mitochondrial structure, organizing cristae, and is essential for ciliogenesis—localized to centrioles and the base of cilia, particularly relevant in sperm flagellar compartmentalization and proper annulus positioning, which is crucial for sperm motility. Mutations in CIBAR1 are associated with disorders such as postaxial polydactyly and certain ciliopathies. While classified structurally as a BAR domain–containing protein (not a classic receptor, enzyme, or transporter), its physiological significance is pronounced in mitochondrial morphology and ciliary function, particularly in reproductive and developmental processes. CIBAR1 is not currently considered a direct therapeutic target (such as a receptor or enzyme); it is a structural protein primarily involved in cell organization and development. There are no known drugs, small molecules, or established clinical biomarkers associated with this protein. No notable safety concerns or therapeutic challenges are currently documented for CIBAR1 inhibition or modulation in humans. CIBAR1 is a BAR domain-containing adaptor/scaffold protein essential for mitochondrial and ciliary structure, involved in male fertility, limb development, and congenital disorders linked to ciliogenesis defects, but is not a classical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CBY1-interacting BAR domain-containing protein 1 (CIBAR1).